VISION Newsletter September 2017
News on Novartis’ innovative new drug Kymriah – Northdale Pietermaritzburg support group – Post-treatment’s new normal – Roche in talks to make trastuzumab available in the public sector – Reach for Recovery celebrates 50 years of care and support – and much, much more.
The monthly VISION cancer e-newsletter is emailed free to people interested in cancer related news and activities. There is no charge for subscribing and anyone who wishes to receive it monthly should simply send an email with “New subscriber” in the subject line to email@example.com.
This mailing list is confidential and is not made available to anyone else to use.
Your comments on the contents of the newsletter and any suggestions for future articles would be welcomed. If you have any news, events, letters or photographs you would like to submit for consideration or if you run a support group, please contact us with details.